Literature DB >> 1587740

Value of grading squamous cell carcinoma of the head and neck.

N J Roland1, A W Caslin, J Nash, P M Stell.   

Abstract

We report a series of 3,294 patients with squamous cell carcinoma of the head and neck seen by one of us between 1963 and 1990. Two thousand and seven patients had a histologically proven and graded, but previously untreated, squamous cell carcinoma of the mucosal surfaces of the head and neck. These tumors had been graded previously by many different pathologists in many different hospitals, both in the United Kingdom and the United States, as well as continental Europe, over this period. Of the host factors both sex and age were associated with differentiation: 34% of patients less than age 50 had a well-differentiated tumor compared with 44% greater than age 50; 32% of women had a poorly differentiated tumor compared with 26% of men. General condition had no correlation with degree of differentiation. Site was closely associated with grading: well-differentiated tumors were more common in the mouth and larynx and poorly differentiated tumors in the pharynx. Furthermore, of poorly differentiated tumors, 19% arose from areas normally lined by keratinized squamous epithelium, 22% from a nonkeratinized area, 36% from respiratory epithelium, and 45% from areas normally covered by lymphoid epithelium. T stage had no significant correlation with differentiation. However, 46% of patients with poorly differentiated tumors had a nodal metastasis at presentation compared with only 28% of well-differentiated tumors. Distant metastases at presentation were found in 3.4% of poorly differentiated tumors compared with 1.8% of well-differentiated tumors. The survival fell significantly from 33% for well-differentiated tumors to 27% for poorly differentiated tumors. The recurrence rate at the primary site rose from 25% for well-differentiated tumors to 27% for poorly differentiated tumors, and recurrence in the lymph nodes rose from 26% to 30%. Both differences were just significant.

Entities:  

Mesh:

Year:  1992        PMID: 1587740     DOI: 10.1002/hed.2880140310

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  24 in total

1.  ACP Best Practice No 157. Guidelines for the laboratory handling of laryngectomy specimens.

Authors:  T R Helliwell
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.

Authors:  Haiquan Lu; Yang Lu; Yangyiran Xie; Songbo Qiu; Xinqun Li; Zhen Fan
Journal:  JCI Insight       Date:  2019-10-03

Review 3.  Biologic markers, cellular differentiation, and metastatic head and neck cancer.

Authors:  S P Schantz
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Histopathologic predictors of lymph node metastasis and prognosis in tonsillar squamous cell carcinoma.

Authors:  Dong Jin Lee; Mi Jung Kwon; Eun Sook Nam; Ji Hyun Kwon; Jin Hwan Kim; Young-Soo Rho; Hyung Sik Shin; Seong Jin Cho
Journal:  Korean J Pathol       Date:  2013-06-25

5.  Cytoplasmic c-ros oncogene 1 receptor tyrosine kinase expression may be associated with the development of human oral squamous cell carcinoma.

Authors:  Yong Cheng; Yang Sun; Li-Zhen Wang; You-Cheng Yu; Xiaojun Ding
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

6.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.

Authors:  Henning Hanken; Alexander Gröbe; Georg Cachovan; Ralf Smeets; Ronald Simon; Guido Sauter; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

7.  Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.

Authors:  Zoya B Kurago; Aroonwan Lam-ubol; Anton Stetsenko; Chris De La Mater; Yiyi Chen; Deborah V Dawson
Journal:  Head Neck Pathol       Date:  2008-03

8.  Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas.

Authors:  Aurélie Capouillez; Christine Decaestecker; Olivier Filleul; Dominique Chevalier; Frederique Coppée; Xavier Leroy; Alexandra Belayew; Sven Saussez
Journal:  Virchows Arch       Date:  2008-09-30       Impact factor: 4.064

Review 9.  acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx.

Authors:  T R Helliwell
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

10.  Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model.

Authors:  Haodan Dang; Yu Chen; Zhuhua Zhang; Xiaohua Shi; Xingming Chen; Xiaoli Zhu; Bo Hou; Haiqun Xing; Huadan Xue; Zhengyu Jin
Journal:  Dentomaxillofac Radiol       Date:  2020-04-03       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.